Glutathione as a Prognostic Biomarker and a Potential Therapeutic Target for Ovarian Cancer

ISSN Print: 2160-8792
ISSN Online: 2160-8806
www.scirp.net/journal/ojog
E-mail: [email protected]

Citations

"Glutathione as a Prognostic Biomarker and a Potential Therapeutic Target for Ovarian Cancer"
written by Motoki Takenaka, Tatsuro Furui, Noriko Suzuki, Tiger Koike, Hitomi Aoki, Ken-Ichirou Morishige,
published by Open Journal of Obstetrics and Gynecology, Vol.12 No.1, 2022

has been cited by the following article(s):

[1]	Lipid peroxidation of immune cells in cancer
	Frontiers in Immunology, 2024

[2]	Redox Biomarkers and Matrix Remodeling Molecules in Ovarian Cancer
	Antioxidants, 2024

[1]	Alterations in GSH/GSSG and CyS/CySS redox status in small cell lung cancer patients undergoing chemotherapy Discover Oncology, 2025 DOI:10.1007/s12672-025-03251-2

[2]	Lipid peroxidation of immune cells in cancer Frontiers in Immunology, 2024 DOI:10.3389/fimmu.2023.1322746

[3]	Redox Biomarkers and Matrix Remodeling Molecules in Ovarian Cancer Antioxidants, 2024 DOI:10.3390/antiox13020200